PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Oncology, Essen Medical, Bronx, NY, USA.\', \'Department of Medicine, Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA; National Clinician Scholars Program, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, USA.\', \'Division of Hematology-Oncology Department of Medicine, Zucker School of Medicine at Hofstra/Northwell Health, New Hyde Park, NY, USA.\', \'Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil.\', \'Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.\', \'Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Madison, WI, USA. Electronic address: nduma@wisc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1535-6108(20)30544-410.1016/j.ccell.2020.10.013
?:doi
?:hasPublicationType
?:journal
  • Cancer cell
is ?:pmid of
?:pmid
?:pmid
  • 33098754
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 12.7
?:rankingScore_hIndex
  • 284
?:title
  • The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all